Printer Friendly

SALICK HEALTH CARE OFFERS SYNOPSIS OF REMARKS AT CRUTTENDEN SOUTHERN CALIFORNIA GROWTH STOCK CONFERENCE

Salick Health Care Chairman Sees Greater Consolidation in Health Care Industry; Cost Containment and Managed Care Will be Driving Factors
 NEWPORT BEACH, Calif., Feb. 18 /PRNewswire/ -- The following is a summary of a presentation made by Los Angeles-based Salick Health Care (NASDAQ: SHCI) today at the Cruttenden Southern California Growth Stock Conference:
 Dr. Bernard Salick, chairman and chief executive officer of Salick Health Care, today said the health care companies that will prosper in 1993 and beyond must be able to address the requirements of cost containment effectively and profitably without sacrificing quality; those that are slow or unable to adapt will see their prospects greatly diminished.
 Salick's comments were delivered to a group of institutional investors attending the Cruttenden growth stock conference in Orange County.
 "We anticipated cost containment back in 1985 when we opened our first Comprehensive Cancer Center, at Cedars-Sinai in Los Angeles, to offer patients more comprehensive, cost-effective outpatient cancer diagnosis and treatment," Salick said. "The drive for health care reform has heightened the awareness of a need to reduce costs, particularly hospitalization through alternate site care including outpatient and home care.
 "Change to health care cost and delivery represents a opportunity for Salick Health Care that we have anticipated," Salick added. "Changes to the system, based on managed care and managed competition, will mandate the kind of high quality, disease specific alternate site care we have been offering through our Comprehensive Cancer Centers. We have significantly enhanced our ability to offer complete programs of disease care to managed care payors.
 "Salick Health Care is well positioned for reimbursement changes," Salick explained. "Beginning in 1973 with our dialysis operations, we participated in the country's first fixed reimbursement medical program, the forerunner to the current Diagnostic Related Groupings (DRG) used by Medicare and other payors. With a substantial managed care and Medicare payor base, we are accustomed to operating profitably within reimbursements constraints."
 Salick also noted in his remarks that 5 percent of the U.S. population accounts for 70 percent of health care costs, principally from catastrophic conditions such as end stage renal disease, cancer, organ transplantation, etc. -- areas of medicine which have grown tremendously because of scientific advances. "The availability of quality, cost-effective care in these areas will become increasingly significant," Salick concluded.
 Salick currently operates nine Comprehensive Cancer Centers throughout the country which contribute 70 percent of total company revenues. It also operates eight outpatient dialysis centers and provides inpatient dialysis services at 21 hospitals. Through its recently established INFUSX subsidiary, Salick provides various infusion and related services in the patient's home and at specialized facilities for the treatment of complex chronic diseases.
 -0- 2/18/93
 /CONTACT: John Shaw of The Financial Relations Board/LA, 818-783-2400; or Les Bell, executive VP and CFO of Salick Health Care, 213-966-3410/
 (SHCI)


CO: Salick Health Care ST: California IN: HEA SU:

JL-JB -- LA024 -- 7697 02/18/93 08:52 EST
COPYRIGHT 1993 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 1993 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Feb 18, 1993
Words:484
Previous Article:SAFEGUARD HEALTH ENTERPRISES INC. OFFERS SYNOPSIS OF REMARKS MADE AT CRUTTENDEN SOUTHERN CALIFORNIA GROWTH STOCK CONFERENCE
Next Article:DREAMS ON DISPLAY
Topics:


Related Articles
HELIAN HEALTH GROUP INC. OFFERS SYNOPSIS OF REMARKS AT CRUTTENDEN SOUTHERN CALIFORNIA GROWTH STOCK CONFERENCE
SAFEGUARD HEALTH ENTERPRISES INC. OFFERS SYNOPSIS OF REMARKS MADE AT CRUTTENDEN SOUTHERN CALIFORNIA GROWTH STOCK CONFERENCE
WESTLAKE COMP. CANCER CENTER TO ESTABLISH BONE MARROW TRANSPLANTATION, STEM CELL PHERESIS PROGRAM UNDER DIRECTION OF ROBERT GALE, M.D., PH.D.
SALICK HEALTH CARE AND VALUE HEALTH SCIENCES CREATE BREAKTHROUGH CANCER TREATMENT GUIDELINES
SALICK HEALTH CARE REPORTS FOURTH QUARTER, FISCAL 1994 RESULTS; COMPANY'S 11TH SUCCESSIVE YEAR OF RECORD GROWTH
SALICK HEALTH CARE 1994 ANNUAL MEETING SET FOR APRIL 13
UNIQUE PRACTICE GUIDELINES AND OUTCOMES MEASUREMENTS CONFIRM DRAMATIC SUCCESS IN SALICK HEALTH CARE'S MANAGED CARE PROGRAM FOR CANCER PATIENTS
SALICK HEALTH CARE OPENS TENTH DIALYSIS FACILITY
SALICK HEALTH CARE, INC.(R) REPORTS RECORD THIRD FISCAL QUARTER REVENUES

Terms of use | Copyright © 2016 Farlex, Inc. | Feedback | For webmasters